Yaba College Of Technology Researchers Win Thirty Million Naira (n30, 000,000) Grant In 2020 Tetfund National Research Fund (nrf)

Download Yabatech News Android App

research

Yaba College Of Technology Researchers Win Thirty Million Naira (n30, 000,000) Grant In 2020 Tetfund National Research Fund (nrf)

Research project titled: Evaluation of the Anti-Breast Cancer Potentials of Some herbal combinations with cultivated medicinal mushrooms Ganoderma Species from Lagos State has been awarded the sum of Thirty Million Naira only under the 2020 National Research Fund by TETFund.

The team is led by Dr. (Mrs.) Lauretta Nwanneka Ofodile, Director in the College Central Research Laboratory, Yaba College of Technology, in collaboration with other researchers from the University of Lagos - Dr. Olumide Adedapo Adebesin of the department of Cell Biology and Genetics and Dr. Utom-Obong Udom Akpan and Dr. (Mrs.) Viola A. Nwachukwu Nicholas-Okpara of the Department of Food Technology, Federal Institute of Industrial Research Oshodi (FIIRO) Lagos. Other team members from Yaba College of Technology include Dr. Uche Claris. Kanife, Biological Science Department, Dr. Ndubuisi M. Chikelu Nwakanma of Science Laboratory Technology, Dr. Leonard O. Governor--Adamu and Dr. Emmanuel Ani also from Department of Biological Science. Mr. Emmanuel Mmaduabuchi Ikegwu and Mr.  Adekunle   Ayo Ayodeji are the Statisticians in the Team

The project will mentor two lecturers in Yaba College of Technology- Mr. Godwin Onoriode Ovioma, and Miss Doyinsola O. Akinjayeju from the Department of Biological Sciences, two post-graduate students from the University of Lagos: Mr. Shina Gideon Ojo and Mrs. Oritsejemiyo Esoghe Ejuetueyin, and twenty-five (25) students of Yaba College of Technology.

This research is the continuation of the project funded by Lagos State Research Council in 2014 on the identification, cultivation and determination of the anticancer potential of some Ganoderma species from Lagos state. Three species of the mushroom Ganoderma were found to be antiproliferative against cultured Human Breast Adenocarcinoma (Mcf-7) Cell Line.

The team hopes this fund will aid the formulation of potent anti-breast cancer nutriceuticals that will contribute immensely in the health care sector.